Understanding Freedom to Operate (FTO) Concerning IP & Patents
Kashishipr
DECEMBER 28, 2021
Three pharmaceutical companies, including Enzon Pharmaceuticals, Micromet AG, and Cambridge Antibody Technology (now acquired by AstraZeneca), in September 2003 announced signing a non-exclusive cross-license agreement. The convenience of a licensing agreement majorly depends on the terms and conditions mentioned in it.
Let's personalize your content